Abstract
Hypothalamic/visual pathway astrocytomas in children are usually quiescent, but certain cases contain aggressive neoplasms that cause progressive neurological and visual deterioration. Radiotherapy is not recommended in young children because of its adverse effects later in life. This report describes the efficacy of a chemotherapeutic regimen. Four young children with hypothalamic/visual pathway astrocytoma, with a mean of 18 months of age at diagnosis, were treated with chemotherapy. Three patients had diencephalic syndrome at the disease's onset. Three patients with pilocytic astrocytoma were histologically verified, and another infant was clinically diagnosed. A combination chemotherapy using cisplatin and vincristine was administered in a total of 8 cycles in 3 children and 4 in one child. One patient who demonstrated renal insufficiency after 4 cycles of this regimen was treated with additional 4 cycles using carboplatin instead of cisplatin. The acute and subacute hematologic and otologic toxicities were mild, and a transient renal insufficiency in a child during chemotherapy improved. After chemotherapy, tumor regression was documented in 3 patients, and the disease was observed to be stable in one patient with an evidence of intratumoral necrosis on MRI. Three patients showed neurological and endocrinological improvements. These results suggest that this regimen is feasible in young children and may be useful as a first-line treatment for hypothalamic/visual pathway astrocytomas, which in turn may allow potentially deleterious irradiation on the maturing brain to be deferred until the disease progresses.
Similar content being viewed by others
References
Packer RJ, Savino PJ, Bilaniuk LT, Zimmerman RA, Schatz NJ, Rosenstoch JG, Nelson DS, Jarrett PD, Bruce DA, Schut L: Chiasmatic gliomas of childhood. A reappraisal of natural history and effectiveness of cranial irradiation. Child’s Brain 10: 393–403, 1983
Kretschmar CS, Linggood RM: Chemotherapeutic treatment of extensive optic pathway tumors in infants. J Neuro-Oncol 10: 263–270, 1991
Alvord EC, Lofton S: Gliomas of the optic nerve or chiasm. Outcome by patient’s age, tumor site, and treatment. J Neurosurg 68: 85–98, 1988
Valdueza JM, Lohmann F, Dammann O, Hagel Ch, Eckert B, Freckmann N: Analysis of 20 primarily surgically treated chiasmatic/hypothalamic pilocytic astrocytomas. Acta Neurochir (Wien) 126: 44–50, 1994
Nishio S, Takeshita I, Fujiwara S, Fukui M: Optico-hypothalamic glioma. An analysis of 16 cases. Child’s Nerv Syst 9: 334–338, 1993
Pierce SM, Barnes PD, Loeffler JS, Mcginn C, Tarbell NJ: Definitive radiation therapy in the management of symptomatic patients with optic glioma. Survival and long-term effects. Cancer 65: 45–52, 1990
Weiss L, Sagerman RH, King GA, Chung CT, Dubowy RL: Controversy in the management of optic nerve glioma. Cancer 59: 1000–1004, 1987
Duffner PK, Cohen ME, Thomas PRM, Lansky SB: The long-term effects of cranial irradiation on the central nervous system. Cancer 56: 1841–1846, 1985
Hoffman H, Soloniuk DS, Humphreys RP, Drake JM, Becker LE, De Lima BO, Piatt JH: Management and outcome of low-grade astrocytomas of the midline in children. A retrospective review. Neurosurgery 33: 964–971, 1993
Brauner R, Malandry F, Rappaport R, Zucker JM, Kalifa C, Pierre-Kahn A: Growth and endocrine disorders in optic glioma. Eur J Pediatr 149: 825–828, 1990
Silverman CL, Palkes H, Talent B, Kovnar E, Clouse JW, Thomas PRM: Late effects of radiotherapy on patients with cerebellar medulloblastoma. Cancer 54: 825–829, 1984
Packer RJ, Sutton LN, Bilaniuk LT, Radcliffe J, Rosenstock JG, Siegel KR, Bunin GR, Savino PJ, Bruce DA, Schut L: Treatment of chiasmatic/hypothalamic gliomas of childhood with chemotherapy. An update. Ann Neurol 23: 79–85, 1988
Petronio J, Edwards MSB, Prados M, Freyberger S, Rabbitt J, Silver P, Levin VA: Management of chiasmal and hypothalamic gliomas of infancy and childhood with chemotherapy. J Neurosurg 74: 701–708, 1991
Moghrabi A, Friedman HS, Burger PC, Tien R, Oakes WJ: Carboplatin treatment of progressive optic pathway gliomas to delay radiotherapy. J Neurosurg 79: 223–227, 1993
Packer RJ, Lange B, Ater J, Nicholson HS, Allen J, Walker R, Prados M, Jakacki R, Reaman G, Needles MN, Phillips PC, Ryan J, Boyett JM, Geyer R, Finlay J: Carboplatin and vincristine for recurrent and newly diagnosed low-grade gliomas of childhood. J Clin Oncol 11: 850–856, 1993
Brown MT, Friedman HS, Oakes WJ, Boyko OB, Hockenberger B, Schold SC: Chemotherapy for pilocytic astrocytomas. Cancer 71: 3165–3172, 1993
Nishio S, Morioka T, Takeshita I, Shono T, Inamura T, Fujiwara S, Fukui M: Chemotherapy for progressive pilocytic astrocytomas in the chiasmo-hypothalamic regions. Clin Neurol Neurosurg 97: 300–306, 1995
Chamberlain MC, Levin VA: Chemotherapeutic treatment of the diencephalic syndrome. Cancer 63: 1681–1684, 1989
Sutton LN, Molloy PT, Sernyak H, Goldwein J, Phillips PL, Rorke LB, Moshang T, Lange B, Packer RJ: Long-term outcome of hypothalamic/chiasmatic astrocytomas in children treated with conservative surgery. J Neurosurg 83: 583–589, 1995
Allen JC, Bosl G, Walker R: Chemotherapy trials in recurrent primary intracranial germ cell tumors. J Neurooncol 3: 147–152, 1985
Kovnar EH, Kellie SJ, Horowitz ME, Stanford RA, Langston JW, Mulharn RK, Jenkins JJ, Douglass EC, Etcubanas EE, Fairclough DL, Kun LE: Preirradiation cisplatin and etoposide in the treatment of high-risk medulloblastoma and other malignant embryonal tumors of the central nervous system. A phase II study. J Clin Oncol 8: 330–336, 1990
Pendergrass TW, Milstein JM, Geyer JR, Mulne AF, Kosnik EJ, Morris JD, Heideman RL, Ruymann FB, Stuntz JT, Bleyer WA: Eight drugs in one day chemotherapy for brain tumors. Experience in 107 children and rationale for preirradiation chemotherapy. J Clin Oncol 5: 1221–1231, 1987
Sawamura Y, Ikeda J, Ishii N, Kato T, Tada M, Abe H, Shirato H: Combined irradiation and chemotherapy using ifosfamide, cisplatin, and etoposide for children with medulloblastoma/posterior fossa primitive neuroectodermal tumor. Results of pilot study. Neuro Med Chir (Tokyo) 36: 631–637, 1996
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kato, T., Sawamura, Y., Tada, M. et al. Cisplatin/vincristine chemotherapy for hypothalamic/visual pathway astrocytomas in young children. J Neurooncol 37, 263–270 (1998). https://doi.org/10.1023/A:1005866021835
Issue Date:
DOI: https://doi.org/10.1023/A:1005866021835